Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Metabolic shift toward oxidative phosphorylation in docetaxel resistant prostate cancer cells.

Oncotarget - 20 Sept 2016

Ippolito Luigi, Marini Alberto, Cavallini Lorenzo, Morandi Andrea, Pietrovito Laura, Pintus Gianfranco, Giannoni Elisa, Schrader Thomas, Puhr Martin, Chiarugi Paola, Taddei Maria Letizia

Abstract excerpt

Drug resistance of cancer cells is recognized as the primary cause of failure of chemotherapeutic treatment in most human cancers. Growing evidences support the idea that deregulated cellular metabolism is linked to such resistance. Indeed, both components of the glycolytic and mitochondrial pathways are involved in altered metabolism linked to chemoresistance of several cancers. Here we investigated the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Docetaxel
Share to Epithelial-Mesenchymal Transition

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Glutamine

Share to Glycolysis

Share to Oxidative Phosphorylation

Share to Prostate

Share to Taxoids

Source

Open in PubMed Open full text

Identifiers

PMID: 27542265
DOI: 10.18632/oncotarget.11301
PMCID: PMC5308698

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Metabolic shift toward oxidative phosphorylation in docetaxel resistant prostate cancer cells.PMID 27542265Read ↗

Cisplatin-Resistant Urothelial Bladder Cancer Cells Undergo Metabolic Reprogramming beyond the Warburg EffectSemantic proximity Read ↗

Cancer-associated fibroblasts promote prostate cancer malignancy via metabolic rewiring and mitochondrial transferSemantic proximity Read ↗

MYC is a regulator of androgen receptor inhibition-induced metabolic requirements in prostate cancerSemantic proximity Read ↗

Androgen receptor inhibition induces metabolic reprogramming and increased reliance on oxidative mitochondrial metabolism in prostate cancerSemantic proximity Read ↗

Hypoxia and the metabolic phenotype of prostate cancer cells.Semantic proximity Read ↗

Metabolic shift towards oxidative phosphorylation reduces cell-density-induced cancer-stem-cell-like characteristics in prostate cancer in vitroSemantic proximity Read ↗

Metabolic rewiring in melanoma drug-resistant cells.Semantic proximity Read ↗

A glycolytic phenotype is associated with prostate cancer progression and aggressiveness: a role for monocarboxylate transporters as metabolic targets for therapy.Semantic proximity Read ↗

Reprogramming hormone-sensitive prostate cancer to a lethal neuroendocrine cancer lineage by mitochondrial pyruvate carrier (MPC)Semantic proximity Read ↗

Subtype and Site Specific–Induced Metabolic Vulnerabilities in Prostate CancerSemantic proximity Read ↗

Metabolic Reprogramming and Predominance of Solute Carrier Genes during Acquired Enzalutamide Resistance in Prostate CancerSemantic proximity Read ↗

Personalized Medicine for Prostate Cancer: Is Targeting Metabolism a Reality?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.